Threshold values across cost-effectiveness thresholds for intervention cost at levels of effectiveness from published trials
| NSAIDs | Benzodiazepines | PPIs | |
| Intervention effectiveness (risk reduction)* | 0.498 | 0.23 | 0.55 |
| Threshold cost (€) at published intervention effectiveness* | |||
| WTP (€ per QALY) | |||
| 0 | 401 | 798 | 544 |
| 20 000 | 1099 | 1101 | 671 |
| 45 000 | 1971 | 1480 | 831 |
*Effectiveness estimates used were taken from Dreishulte et al for NSAIDs,48 Tannenbaum et al for benzodiazepines49 and Clyne et al for PPIs.47
NSAID, non-steroidal anti-inflammatory drugs; PPI, proton pump inhibitor; QALY, quality-adjusted life year; WTP, willingness-to-pay.